Literature DB >> 33567717

Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus.

Ancuța Cutaș1, Cristina Drugan2, Gabriela Roman3, Adriana Rusu3, Cristina Sorina Cătană2, Andrei Achimaș-Cadariu1, Tudor Drugan1.   

Abstract

The chronic complications of diabetes mellitus (DM) are accompanied by inflammatory manifestations. Our study aimed to evaluate a possible association between the inflammatory status (reflected by serum chitotriosidase and neopterin) and the timely evolution and occurrence of chronic microvascular complications in patients with type 1 DM. This observational, cross-sectional study included 82 type 1 DM patients from the Centre for Diabetes, Nutrition and Metabolic Diseases, Cluj-Napoca, Romania. Our results demonstrated a link between the extent of inflammation, evaluated by the enzymatic activity of circulating chitotriosidase, and the onset of microvascular complications, especially diabetic neuropathy and retinopathy. Chitotriosidase enzymatic activity showed an ascending evolution over time. In non-smoking patients, the increase in chitotriosidase activity was correlated with the extent of microalbuminuria and the decline of glomerular filtration rate, while in smokers, only the presence of a positive correlation between chitotriosidase activity and disease progression was noticed. According to our results, the time span between the moment of diagnosis and the onset of microvascular complications was longer in non-smokers than in smokers. These results also imply that increased chitotriosidase activity may be a predictor of endothelial dysfunction in type 1 DM.

Entities:  

Keywords:  chitotriosidase; diabetes mellitus; inflammation; microvascular complications; neopterin

Year:  2021        PMID: 33567717      PMCID: PMC7916086          DOI: 10.3390/diagnostics11020263

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  28 in total

Review 1.  Factors affecting A1C in non-diabetic individuals: Review and meta-analysis.

Authors:  Gabriela Cavagnolli; Ana Laura Pimentel; Priscila Aparecida Correa Freitas; Jorge Luiz Gross; Joíza Lins Camargo
Journal:  Clin Chim Acta       Date:  2015-03-27       Impact factor: 3.786

2.  Role of chitotriosidase (chitinase 1) under normal and disease conditions.

Authors:  Manasa Kanneganti; Alan Kamba; Emiko Mizoguchi
Journal:  J Epithel Biol Pharmacol       Date:  2012

Review 3.  Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology.

Authors:  Salvatore De Rosa; Plinio Cirillo; Mario Pacileo; Gianluca Petrillo; Greta-Luana D'Ascoli; Fabio Maresca; Francesca Ziviello; Massimo Chiariello
Journal:  Curr Vasc Pharmacol       Date:  2011-03       Impact factor: 2.719

4.  Evaluation of Chitotriosidase as a Marker of Inflammatory Status in Critical Limb Ischemia.

Authors:  Răzvan A Ciocan; Cristina Drugan; Claudia D Gherman; Cristina-Sorina Cătană; Andra Ciocan; Tudor C Drugan; Sorana D Bolboacă
Journal:  Ann Clin Lab Sci       Date:  2017-11       Impact factor: 1.256

Review 5.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch; W L Suarez-Pinzon
Journal:  Biochem Pharmacol       Date:  1998-04-15       Impact factor: 5.858

6.  Serum chitotriosidase, a putative marker of chronically activated macrophages, increases with normal aging.

Authors:  Rohit Ramanathan; Anita Kohli; María Clara Ingaramo; Alka Jain; Sean X Leng; Naresh M Punjabi; Jeremy D Walston; Neal S Fedarko
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-03-22       Impact factor: 6.053

7.  Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.

Authors:  Fumie Sakamoto; Naoto Katakami; Hideaki Kaneto; Tetsuyuki Yasuda; Mitsuyoshi Takahara; Kazuyuki Miyashita; Akio Kuroda; Munehide Matsuhisa; Keisuke Kosugi; Iichiro Shimomura
Journal:  Endocr J       Date:  2012-10-15       Impact factor: 2.349

Review 8.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

9.  Serum chitotriosidase enzyme activity is closely related to HbA1c levels and the complications in patients with diabetes mellitus type 2.

Authors:  Emre Turan; Bulent Sozmen; Mine Eltutan; Eser Y Sozmen
Journal:  Diabetes Metab Syndr       Date:  2017-03-31

10.  Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.

Authors:  Mark E Molitch; Amanda I Adler; Allan Flyvbjerg; Robert G Nelson; Wing-Yee So; Christoph Wanner; Bertram L Kasiske; David C Wheeler; Dick de Zeeuw; Carl E Mogensen
Journal:  Kidney Int       Date:  2014-04-30       Impact factor: 10.612

View more
  3 in total

1.  Evaluation of Circulating Chitotriosidase Activity in Children with Obesity.

Authors:  Ioana Țaranu; Mihaela Iancu; Cecilia Lazea; Camelia Alkhzouz; Nicoleta Răcătăianu; Cristina-Sorina Cătană; Andreea-Manuela Mirea; Diana Miclea; Sorana D Bolboacă; Cristina Drugan
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

2.  Trehalose Activates Hepatic and Myocardial Autophagy and Has Anti-Inflammatory Effects in db/db Diabetic Mice.

Authors:  Tatiana A Korolenko; Marina V Ovsyukova; Nataliya P Bgatova; Igor D Ivanov; Svetlana I Makarova; Valentin A Vavilin; Alexey V Popov; Ekaterina I Yuzhik; Elena V Koldysheva; Erik C Korolenko; Evgeny L Zavjalov; Tamara G Amstislavskaya
Journal:  Life (Basel)       Date:  2022-03-17

3.  Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes.

Authors:  Long-Yi Zheng; Jin Lu; Ren-Hui Wan; Yang Yuan; Wei Hao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-28       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.